We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
LAURUSLABS.NSE

Price
605.85
Stock movement up
+41.60 (7.37%)
Company name
Laurus Labs Limited
Exchange
(NSE
,
Currency
INR
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
326.65B
Ent value
372.07B
Price/Sales
6.46
Price/Book
7.88
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
249.16
Forward P/E
25.92
PEG
-
EPS growth
11.03%
1 year return
31.01%
3 year return
0.90%
5 year return
51.99%
10 year return
-
Last updated: 2025-04-15

DIVIDENDS

LAURUSLABS.NSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E249.16
Price to OCF165.96
Price to FCF165.96
Price to EBITDA177.67
EV to EBITDA202.38

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales6.46
Price to Book7.88
EV to Sales7.36

FINANCIALS

Per share

Per share data
Current share count539.16M
EPS (TTM)2.44
FCF per share (TTM)3.67

Income statement

Income statement data
Revenue (TTM)50.53B
Gross profit (TTM)21.57B
Operating income (TTM)3.61B
Net income (TTM)1.31B
EPS (TTM)2.44
EPS (1y forward)23.37

Margins

Margins data
Gross margin (TTM)42.69%
Operating margin (TTM)7.14%
Profit margin (TTM)2.59%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash432.20M
Net receivables17.51B
Total current assets41.20B
Goodwill2.46B
Intangible assets170.00M
Property, plant and equipment0.00
Total assets87.29B
Accounts payable10.58B
Short/Current long term debt27.89B
Total current liabilities34.59B
Total liabilities45.85B
Shareholder's equity41.44B
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)1.97B
Capital expenditures (TTM)0.00
Free cash flow (TTM)1.97B
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity3.16%
Return on Assets1.50%
Return on Invested Capital2.11%
Cash Return on Invested Capital3.17%

STOCK INFORMATION

Stock chart

Stock price data
Open585.00
Daily high608.00
Daily low576.90
Daily Volume3.44M
All-time high708.70
1y analyst estimate418.36
Beta1.12
EPS (TTM)2.44
Dividend per share-
Ex-div date6 Nov 2024
Next earnings date23 Apr 2025

Downside potential

Downside potential data
LAURUSLABS.NSES&P500
Current price drop from All-time high-14.51%-12.89%
Highest price drop-59.12%-56.47%
Date of highest drop28 Mar 20239 Mar 2009
Avg drop from high-26.79%-11.07%
Avg time to new high22 days12 days
Max time to new high909 days1805 days
COMPANY DETAILS
LAURUSLABS.NSE (Laurus Labs Limited) company logo
Marketcap
326.65B
Marketcap category
Large-cap
Description
Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides oral solid formulations for ARVs, anti-diabetic, cardiovascular, and PPIs. In addition, the company offers contract development and manufacturing organizational services; and biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. Further, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.
Employees
6007
Website
https://www.lauruslabs.com
Investor relations
-
SEC filings
LAURUSLABS.NSE SEC filings
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
No events found
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved